MedTrace Logo

Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

NCT02269982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-06-10

No results posted yet for this study

Summary

This study will develop a first-in-man CTC-based molecular taxonomy of CRPC in the context of novel AR-directed therapies, categorize different patterns of resistance in this disease setting, and describe their evolution over time and treatment.

Conditions

Interventions

DEVICE

AR-v7 assays

Sponsors & Collaborators

Principal Investigators

  • Andrew J Armstrong, MD · Duke University

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-14
Primary Completion
2017-09-01
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02269982 on ClinicalTrials.gov